Corporate Reputation of Pharma in Canada, 2023/2024: The Views of 100 Canadian Patient Groups - Fair Pricing Policies, Transparency of Pricing, and Engaging Patients in R&D Among the Lowest-Scoring Indicators
26 juin 2024 09h25 HE
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups" report has been...
Corporate Reputation of Pharma in 2023/2024: The Patient Perspective and Views of 2,500+ Patient Groups - Pharma Corporate Reputation Falls from COVID Highs
26 juin 2024 06h51 HE
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide" report has...
Survey Results of 830+ Patient Groups on the Pharmaceutical Industry and Environmental, Social, and Governance (ESG) Practices
24 juin 2024 11h44 HE
|
Research and Markets
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World" report has been added to ...
Patient Perspective of 520 Cancer Patient Groups on the Corporate Reputation of Pharma in 2023/2024: Roche Ranked 1st, AstraZeneca Ranked 2nd, and Pfizer Ranked 3rd
21 juin 2024 08h54 HE
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups" report has been...
Global LAG-3 Inhibitors Market, Drug Sales & Clinical Trials Market Report: Featuring Abeome, ABL Bio, Agenus, Akeso Biopharma, AnaptysBio, EpimAb Biotherapeutics, Immutep, Incyte and Y-Biologics
20 juin 2024 04h23 HE
|
Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global LAG-3 Inhibitors Market, Drug Sales & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. In recent...
Global IV & Oral Iron Drugs Market Report 2024: Focused Insights for 2023-2029 - Increasing Prevalence of Iron Deficiency (ID) and Iron Deficiency Anemia (IDA) Driving the Surge in the Industry
09 févr. 2024 08h49 HE
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The global IV and Oral...
Global Sodium Hyaluronate-based Products (Injectable, Topical) Market Size, Share & Trends Analysis Report 2023-2030
24 janv. 2024 10h11 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Sodium Hyaluronate-based Products Market Size, Share & Trends Analysis Report by Type (Injectable, Topical), Application {Pharmaceuticals...
Europe Parenteral Lipid Emulsion Market Trends Analysis Report 2023-2030
24 nov. 2023 09h18 HE
|
Research and Markets
Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "Europe Parenteral Lipid Emulsion Market Size, Share & Trends Analysis Report By Ingredient (1st Generation Lipid Emulsions, 2nd Generation Lipid...
Global LAG-3 Inhibitor Market Research Report 2023-2028: Opdualag and 35 Drugs in Trial - Drug Sales, Prices & Clinical Trials Insights
22 mai 2023 09h38 HE
|
Research and Markets
Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. In...
Drafting Effective Pharmaceutical Patents Training Course
22 mai 2023 04h53 HE
|
Research and Markets
Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Drafting Effective Pharmaceutical Patents Training Course" conference has been added to ResearchAndMarkets.com's offering. The highly complex area of...